Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Tumorigenic Activity of 3-Methylcholanthrene Metabolites on Mouse Skin and in Newborn Mice

W. Levin, M. K. Buening, A. W. Wood, R. L. Chang, D. R. Thakker, D. M. Jerina and A. H. Conney
W. Levin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. K. Buening
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. W. Wood
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. L. Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. R. Thakker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. M. Jerina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. H. Conney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 1979
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

3-Methylcholanthrene and eight of its metabolites were tested for tumorigenic activity in two tumor models. In the tumorigenicity study on mouse skin, a single topical application of 3 to 30 nmol of compound was followed 7 days later by twice weekly applications of the tumor promotor 12-O-tetradecanoylphorbol-13-acetate for 30 weeks. Comparisons of the percentage of mice with tumors and the average number of tumors per mouse indicated that 3-methylcholanthrene, 2-hydroxy-3-methylcholanthrene, 3-methylcholanthrene-2-one, and a 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene diastereomer were approximately equipotent as tumor initiators. 1-Hydroxy-3-methylcholanthrene had approximately one-fourth the tumor-initiating activity of the most active compounds, and 3-methylcholanthrene-1-one and trans-11,12-dihydroxy-11,12-dihydro-3-methylcholanthrene had no significant tumorigenic activity at the doses tested. In the tumorigenicity study in newborn mice, increasing amounts of the compounds were injected i.p. on the 1st, 8th, and 15th days of life to give a total dose of 21 or 49 nmol. The experiment was terminated when the animals were 35 to 39 weeks old. With respect to pulmonary tumors, 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene was the most tumorigenic compound tested at both doses. 3-Methylcholanthrene and 3-methylcholanthrene-2-one were the next most active compounds, and they had approximately one-half to one-third of the activity of 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene when the data were expressed as pulmonary tumors per mouse. 2-Hydroxy-3-methylcholanthrene was slightly less active than were 3-methylcholanthrene and 3-methylcholanthrene-2-one. 1-Hydroxy-3-methylcholanthrene had marginal tumorigenic activity. 3-Methylcholanthrene 11,12-oxide, trans-11,12-dihydroxy-11,12-dihydro-3-methylcholanthrene, and 3-methylcholanthrene-1-one were inactive at the doses tested.

1,9,10-Trihydroxy-9,10-dihydro-3-methylcholanthrene at the 21- and 49-nmol doses also produced hepatic tumors in 50 and 81% of the male mice, respectively. 3-Methylcholanthrene and 2-hydroxy-3-methylcholanthrene had one-fourth to one-tenth the activity of 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene in the liver. The other 3-methylcholanthrene metabolites were essentially inactive in producing hepatic tumors. The high tumorigenic activity of 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene on mouse skin and in newborn mice provides evidence for bay-region activation of 3-methylcholanthrene to an ultimate carcinogen. The data also indicate that other metabolites of 3-methylcholanthrene may play a role in the carcinogenicity of this polycyclic aromatic hydrocarbon.

Footnotes

  • ↵1 To whom requests for reprints should be addressed.

  • Received January 25, 1979.
  • Accepted June 8, 1979.
  • ©1979 American Association for Cancer Research.
PreviousNext
Back to top
September 1979
Volume 39, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tumorigenic Activity of 3-Methylcholanthrene Metabolites on Mouse Skin and in Newborn Mice
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Tumorigenic Activity of 3-Methylcholanthrene Metabolites on Mouse Skin and in Newborn Mice
W. Levin, M. K. Buening, A. W. Wood, R. L. Chang, D. R. Thakker, D. M. Jerina and A. H. Conney
Cancer Res September 1 1979 (39) (9) 3549-3553;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumorigenic Activity of 3-Methylcholanthrene Metabolites on Mouse Skin and in Newborn Mice
W. Levin, M. K. Buening, A. W. Wood, R. L. Chang, D. R. Thakker, D. M. Jerina and A. H. Conney
Cancer Res September 1 1979 (39) (9) 3549-3553;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Membership of Advisory Council
  • Introduction of H. Robert Horvitz
  • Mammary Gland Development, Reproductive History, and Breast Cancer Risk
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement